HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Onyx pulmonary artery embolization after treatment of a low-flow dural arteriovenous fistula: case report.

AbstractBACKGROUND AND IMPORTANCE:
Endovascular management of dural arteriovenous fistulas (DAVFs) has become an accepted primary and often definitive therapy. We present the first documented case of Onyx pulmonary embolism after embolization of a low-flow DAVF.
CLINICAL PRESENTATION:
A 63-year-old man presented with subarachnoid hemorrhage secondary to a DAVF. Computed tomographic angiography, magnetic resonance imaging, and initial conventional angiogram were negative. A repeat angiogram demonstrated a DAVF, which was cured with Onyx embolization. A routine chest computed tomography after intervention revealed an asymptomatic Onyx embolization cast in a subsegmental pulmonary artery.
CONCLUSION:
Endovascular treatment options include transarterial embolization with microcoils, polyvinyl alcohol particles, n-butyl-2cyanoacrylate, and Onyx (ev3 Neurovascular, Irvine, California). Complications associated with the use of Onyx are low but include embolizate pulmonary embolism. Patients often remain asymptomatic, but for symptomatic patients, conservative treatment options usually result in resolution of symptoms.
AuthorsBryan A Pukenas, Sudhakar R Satti, Robert Bailey, John B Weigele, Robert W Hurst, Michael F Stiefel
JournalNeurosurgery (Neurosurgery) Vol. 68 Issue 5 Pg. E1497-500; discussion E1500 (May 2011) ISSN: 1524-4040 [Electronic] United States
PMID21307786 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Drug Combinations
  • Onyx 18
  • Polyvinyls
  • Tantalum
Topics
  • Central Nervous System Vascular Malformations (diagnostic imaging, therapy)
  • Drug Combinations
  • Embolization, Therapeutic (methods)
  • Humans
  • Male
  • Middle Aged
  • Polyvinyls
  • Pulmonary Artery (diagnostic imaging)
  • Radiography
  • Tantalum
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: